Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (2)

Boston College: Chestnut Hill, MA, US

1990-09-01 to present | Professor (Biology)
Employment
Source: Self-asserted source
Charles Hoffman

Harvard Medical School: Boston, MA, US

1986-09-01 to 1990-08-15 | Postdoctoral Fellow (Genetics)
Employment
Source: Self-asserted source
Charles Hoffman

Education and qualifications (2)

Tufts University - Boston Campus: Boston, MA, US

1980-09-01 to 1986-07-01 | PhD (Molecular Biology and Microbiology)
Education
Source: Self-asserted source
Charles Hoffman

Massachusetts Institute of Technology: Cambridge, MA, US

1976-09-01 to 1980-06-01 | SB (Biology)
Education
Source: Self-asserted source
Charles Hoffman

Professional activities (6)

Scotch Malt Whisky Society of America: New York City, NY, US

Member Ambassador for Boston
Membership
Source: Self-asserted source
Charles Hoffman

Luxuriant Flowing Hair Club for Scientists: Cambridge, MA, US

Membership
Source: Self-asserted source
Charles Hoffman

Genetics Society of America: Bethesda, MD, US

Membership
Source: Self-asserted source
Charles Hoffman

American Society for Microbiology: Washington, DC, US

Membership
Source: Self-asserted source
Charles Hoffman

American Association for the Advancement of Science: DC, DC, US

Membership
Source: Self-asserted source
Charles Hoffman

NCATS/NIH: Rockville, MD, US

2017-11-01 to 2025-04-30 | Visiting Scientist (Assay Development and Screening Technology)
Invited position
Source: Self-asserted source
Charles Hoffman

Funding (8)

Testing the specificity and efficacy of compounds that inhibit cAMP signaling, for the development of potential therapeutics for FD/MAS

2024-02 to 2025-02 | Grant
Orphan Disease Foundation (Philadelphia, PA, US)
Source: Self-asserted source
Charles Hoffman

Pharmacologic Inhibition of PDE11A for Age-Related Memory Disorders

2020-09-15 to 2025-04-30 | Grant
National Institute on Aging (Baltimore, US)
URL: https://app.dimensions.ai/details/grant/grant.9411931
GRANT_NUMBER: R01AG067836
Source: Self-asserted source
Charles Hoffman via DimensionsWizard

Identification and characterization of novel cell-permeable, small molecule adenylyl cyclase inhibitors for future development as drugs to treat FD/MAS

2019-02 to 2020-01 | Grant
Orphan Disease Foundation (Philadelphia PA, US)
GRANT_NUMBER:

MDBR-19-112-FD/MAS
Source: Self-asserted source
Charles Hoffman

Small molecule HTSs for AC and GNAS inhibitors

2018-09 to 2019-09 | Contract
National Institutes of Health (Md., Md., US)
GRANT_NUMBER:

H5106841
Source: Self-asserted source
Charles Hoffman

EAGER: Selective Biodamage with Shaped THz Light Fields

2018-01 to 2019-07 | Grant
National Science Foundation (VA, VA, US)
Part of GRANT_NUMBER:

1748906
Source: Self-asserted source
Charles Hoffman

An in vivo screen for biological and chemical regulators of mammalial PDEs

2007-01-01 to 2009-06-30 | Grant
National Institute of General Medical Sciences (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.2612132
GRANT_NUMBER: R21GM079662
Source: Self-asserted source
Charles Hoffman via DimensionsWizard

Characterization of the S. Pombe cAMP Pathway

1991-07-01 to 2007-03-31 | Grant
National Institute of General Medical Sciences (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.2513517
GRANT_NUMBER: R01GM046226
Source: Self-asserted source
Charles Hoffman via DimensionsWizard

S POMBE CAMP SIGNAL PATHWAY

1991-07-01 to 1996-06-30 | Grant
National Institute of General Medical Sciences (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.2628592
GRANT_NUMBER: R29GM046226
Source: Self-asserted source
Charles Hoffman via DimensionsWizard
How many people are using ORCID?